METHOD OF TREATING PATIENTS WITH TYPE 2 DIABETES MELLITUS Russian patent published in 2015 - IPC A61N5/06 A61H39/00 

FIELD: medicine.

SUBSTANCE: method starts with a two-staged bioresonance exposure generated by the DETA-Professional apparatus. The first stage represents a baseline therapy and involves 3-5 procedures of the total body exposure, which is ensured by connecting an input electrode upon the measurement procedure to the patient's limb having the highest electromagnetic potential, whereas an output electrode is supposed to be connected to the limb with the lowest electromagnetic potential. Carrying out the exposure observes the following parameters: the first phase is filter-free (FF) at amplification (A) of 20 for 3-4 minutes. The second phase represents the low-frequency (LF) exposure at 1-1,000 Hz, amplification (A) of 16 for 3-4 minutes. The third phase represents the high-frequency (HF) exposure at 1,000-10,000 Hz, amplification (A) of 12 for 3-4 minutes. The exposure is daily. The second stage involves a target therapy consisting of 5-7 procedures of 30-40 minutes each. The exposure covers the entire anatomy of the pancreas and its acupuncture points RP1, RP2, RP3, RP4, TR-1c from the right and left at low frequencies (LF) ranging from 1 to 1,000 Hz, amplification A of 14-35. That is immediately followed by yellow light exposure at a wavelength of 590 nm, intensity of 3 kJ, red light exposure at a wavelength of 650 nm, intensity of 3-4 kJ, and green light exposure at a wavelength of 520 nm, intensity of 4 kJ. At that used is the quasicontinuous radiation mode at a frequency of 1,000 or 80 Hz and the modulated mode at 1,000 or 80 Hz at a modulation of 2 Hz. Each light exposure lasts for no more than 5 minutes and covers a skin projection of the pancreas in the distant mode and the point TR-1 in the contact mode by means of the DETA-Professional apparatus and a phototherapy terminal. Similarly to the first stage, the exposure is daily.

EFFECT: reducing the length of treatment in the given category of patients as a result of lower blood glucose as late as the early stage of treatment with keeping the permanent result in the remote period by a certain stage-by-stage approach of the bioresonance exposure and radiation modes.

1 tbl, 3 ex